More Vista Pharmaceuticals Ltd. news
Vista Pharmaceuticals Ltd.BSE: VISTAPH

Intimation Of Book Closure Regarding 34" Annual General Meeting

Sep 8, 2025 at 6:48 AM EDT · Issued by Vista Pharmaceuticals Ltd. via BSE India

Filed with BSE · Sep 8, 2025 at 6:48 AM EDT

On 6ix: 6ix.com/news/intimation-of-book-closure-regarding-34-annual-general-meeting

Intimation of Book Closure regrading 34th Annual General Meeting of the company

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Vista Pharmaceuticals Ltd. on 6ix

Earlier from Vista Pharmaceuticals

  • Reg. 34 (1) Annual Report.Sep 8, 2025
  • 34Th Annual General Meeting Of Vista Pharmaceuticals Limited On Tuesday, 30Th September 2025Sep 8, 2025
  • Vista Pharmaceuticals Ltd. Press Release Aug 13 2025Aug 13, 2025
  • Re-Appointment Of Mr. Murali Meraga (DIN: 02537507) As An Managing Director Of The CompanyAug 13, 2025
  • Re-Appointment Of Mr. Pavan Sathvik Gilaka (DIN: 09733182) As An Whole Time Director Of The CompanyAug 13, 2025

Later from Vista Pharmaceuticals

  • Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 9, 2025
  • Vista Pharmaceuticals Ltd. Press Release Sep 09 2025Sep 9, 2025
  • Closure of Trading WindowSep 25, 2025
  • Vista Pharmaceuticals Ltd. Press Release Sep 25 2025Sep 25, 2025
  • Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
All Vista Pharmaceuticals news releases↗

Follow Vista Pharmaceuticals into a list and get an email when it puts out news.

Follow Vista Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer